Physician profile
Max Epperson Mitchell
NPI 1174995500
$732.14
in general payments reported to CMS, 2019-2025
10 companies · $372 in 2025
The $372 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $59.81 · 2022: $152 · 2023: $48.89 · 2024: $98.91 · 2025: $372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $520.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urgo Medical North America, LLC | $300.41 | 2025 | Urgoclean Ag |
| Kci USA, INC. | $132.04 | 2021-2023 | Activ.A.C., Prevena, V.A.C. Veraflo Cleanse Choice |
| Solventum Corporation | $89.60 | 2024-2025 | Activ.A.C., V.A.C. Veraflo, 3m Cavilon |
| Abbvie INC. | $43.57 | 2023-2024 | |
| Medline Industries LP | $39.38 | 2022 | |
| Smith+Nephew, INC. | $35.50 | 2021-2022 | |
| Convatec INC. | $31.10 | 2021 | |
| Mimedx Group, INC. | $21.57 | 2024 | |
| Integra Lifesciences Corporation | $21.19 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Molnlycke Health Care US, LLC | $17.78 | 2024 | Mepilex Border Post-Op, Exufiber, Mepitel One |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Max Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.